Ember LifeSciences recently secured $16.5 million in Series A funding. Cold chain failures cost pharma billions, creating demand for tighter temperature control in transport. The company's Ember Cube ...
LOS ANGELES, Feb. 27, 2024 /PRNewswire/ -- Ember LifeSciences, an innovator in the pharmaceutical cold chain industry and creator of the award-winning Ember Cube, and the U.S. Anti-Doping Agency ...
LOS ANGELES, Jan. 28, 2026 /PRNewswire/ -- Ember LifeSciences, Inc. ("Ember") a leading provider of revolutionary cold chain technology, will present and exhibit at Manifest Vegas 2026, the premier ...
When COVID-19 vaccines arrived in 2020, humanity had engineered a modern miracle. But there was a catch: We quickly learned that the Pfizer vaccine had to be shipped at ultra-cold temperatures, as low ...
The Ember Cube is a self-refrigerated, reusable shipping box designed to safely transport and protect temperature-sensitive medicines and vaccines. Its technology allows senders and recipients to ...
LOS ANGELES, Dec. 16, 2025 /PRNewswire/ -- Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court ...
Ember LifeSciences appoints Ann Hyllengren as CFO to guide growth and operational strategy in cold chain and refrigerated shipping. Hyllengren brings nearly two decades at Amgen, including senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results